Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Graeber

Showing results (71-80 of 158) with videos related to

Pageof 16
Sort By:
Molecular Systems Biology|June 28, 2012
Glucose deprivation activates a metabolic and signaling amplification loop leading to cell deathNicholas A Graham, Martik Tahmasian, Bitika Kohli, et al.
Annals of Surgical Oncology|February 15, 2018
Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic CancerColin M Court, Jacob S Ankeny, Shonan Sho, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2006
Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutantsBrian J Skaggs, Mercedes E Gorre, Ann Ryvkin, et al.
BMJ Oncology|April 8, 2025
Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expressionSara Huerta-Yepez, Po-Chun Chen, Kawaljit Kaur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
CTLA4 blockade broadens the peripheral T-cell receptor repertoireLidia Robert, Jennifer Tsoi, Xiaoyan Wang, et al.
The Journal of Molecular Diagnostics : JMD|July 5, 2016
Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic CancerColin M Court, Jacob S Ankeny, Shonan Sho, et al.
Molecular Cancer|July 3, 2015
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Nature Medicine|May 10, 2005
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cellsStephan R Krutzik, Belinda Tan, Huiying Li, et al.
Molecular Cancer|August 22, 2014
Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Nature Communications|August 30, 2020
Defining the ATPome reveals cross-optimization of metabolic pathwaysNeal K Bennett, Mai K Nguyen, Maxwell A Darch, et al.
Pageof 16

Showing results (71-80 of 158) with videos related to

Sort By:
Pageof 16
Molecular Systems Biology|June 28, 2012
Glucose deprivation activates a metabolic and signaling amplification loop leading to cell deathNicholas A Graham, Martik Tahmasian, Bitika Kohli, et al.
Annals of Surgical Oncology|February 15, 2018
Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic CancerColin M Court, Jacob S Ankeny, Shonan Sho, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2006
Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutantsBrian J Skaggs, Mercedes E Gorre, Ann Ryvkin, et al.
BMJ Oncology|April 8, 2025
Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expressionSara Huerta-Yepez, Po-Chun Chen, Kawaljit Kaur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
CTLA4 blockade broadens the peripheral T-cell receptor repertoireLidia Robert, Jennifer Tsoi, Xiaoyan Wang, et al.
The Journal of Molecular Diagnostics : JMD|July 5, 2016
Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic CancerColin M Court, Jacob S Ankeny, Shonan Sho, et al.
Molecular Cancer|July 3, 2015
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Nature Medicine|May 10, 2005
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cellsStephan R Krutzik, Belinda Tan, Huiying Li, et al.
Molecular Cancer|August 22, 2014
Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanomaDeborah J L Wong, Lidia Robert, Mohammad S Atefi, et al.
Nature Communications|August 30, 2020
Defining the ATPome reveals cross-optimization of metabolic pathwaysNeal K Bennett, Mai K Nguyen, Maxwell A Darch, et al.
Pageof 16